Summary

Fairfield Market Research's latest analysis reveals that the Anti-biofilm Wound Dressing Market is on a path of significant growth, driven by substantial advancements and increasing demand.Anti-biofilm Wound Dressing Market, projected to reach $897.384 million in 2024 and $1988 million by 2031, with a notable CAGR of 12.0%. Notably, the Chemical Mode of Mechanism segment is expected to lead in revenue generation with a notable CAGR during the forecast period.

Revenue Trends and Historical Analysis

Historically, the market has shown robust growth, with key regions such as the U.S., U.K., China, Japan, and South Korea playing pivotal roles. The rise in injury occurrences, vehicular mishaps, and burn accidents is anticipated to further propel market growth. The need for effective wound care solutions, such as anti-biofilm dressings, is underscored by alarming road-safety statistics from the Association for Safe International Road Travel.

Challenges in the Anti-biofilm Wound Dressing Market

Despite promising growth prospects, the market faces significant challenges. Treating acute and chronic infected wounds with resident biofilm remains a critical issue. Research by Frontiers Media S.A. highlights the complexities of antimicrobial dressing interactions with bacterial load and the biofilm matrix. This research aims to expand the understanding of various antimicrobial dressings' efficiency using an in-vitro biofilm model that mimics human wound environments, presenting a substantial challenge to global market expansion.

Regional Opportunities

The Asia Pacific region is projected to offer significant growth opportunities, with Japan, India, and China expected to drive market expansion. The region's growing medical tourism industry is likely to propel the demand for advanced wound care products, fueling market growth.

U.S. Market Analysis

The U.S. is poised to maintain a significant share of the anti-biofilm wound dressing market. Factors such as an increase in sports injuries, traffic accidents, and the presence of key market players are expected to drive growth. Additionally, the well-developed healthcare infrastructure and favorable reimbursement policies are likely to support market expansion.

Category-wise Insights

The Chemical Mode of Mechanism segment is expected to grow rapidly due to the rising prevalence of chronic wounds and an increasing number of surgeries globally. This segment, which previously accounted for a significant market share, is projected to continue growing at a fast pace. Chemical-based anti-biofilm wound dressings, which include ionic silver, iodine, and EDTA, provide multi-faceted activity, facilitating faster and more efficient wound healing. These dressings reduce biofilm load and minimize the risk of recontamination by microorganisms, making them highly effective in treating chronic and acute wounds.

Application Insights

The acute wounds segment has maintained a dominant market share, driven by the increasing incidence of burns, trauma, and surgical procedures worldwide. Acute wounds, such as incisions, abrasions, burns, and punctures, heal following the typical wound-healing process. The primary treatment for these wounds involves wound dressing and biofilm prevention, which are critical to the market's growth.

Competitive Analysis

Key market players are pursuing partnerships, mergers, and acquisitions to strengthen their product portfolios, expand manufacturing facilities, and create competitive differentiation. For instance, Smith & Nephew PLC's acquisition of Osiris Therapeutics, Inc. is aimed at enhancing their advanced wound management product line, thereby expanding their client base and market reach.

Recent Developments

Recent developments in the anti-biofilm wound dressing market include:

•Imbed Biosciences partnering with Spartan Medical to provide access to the Microlyte Matrix and Microlyte Surgical product lines through a VA IDIQ Contract with the US Federal Government and Spartan Medical's Distribution and Pricing Agreement.

•ConvaTec Group Plc launching the ConvaMax product, targeting various types of ulcers and dehisced surgical wounds, available in non-adhesive forms for added versatility in treatment regimens.

•Smith & Nephew PLC acquiring Osiris Therapeutics, Inc., aimed at bolstering their Advanced Wound Management franchise.

Market Segmentation

The Anti-biofilm Wound Dressing Market is segmented by mode of mechanism, application, and region:

By Mode of Mechanism:

•Physical (Manual Debridement, Pulse Electrical Field, Ultrasound Debridement, Others)

•Chemical (Ionic Silver, Iodine, EDTA, Others)

•Biological (Dispersin B, Lactoferrin, Bacteriophage, Others)

By Application:

•Chronic Wounds (Diabetic Foot Ulcers, Pressure Ulcers, Venous Leg Ulcers, Others)

•Acute Wounds (Surgical & Traumatic Wounds, Burn Wounds, Others)

By Region:

•North America (U.S., Canada, Rest of North America)

•Europe (France, Germany, UK, Italy, Spain, Netherlands, Austria, Rest of Europe)

•Asia Pacific (Japan, China, India, Malaysia, Indonesia, South Korea, Rest of Asia Pacific)

•Latin America (Brazil, Mexico, Argentina, Rest of Latin America)

•MEA (South Africa, Saudi Arabia, UAE, Israel, Rest of MEA)

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1. Global Anti-biofilm Wound Dressing Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2023
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global Anti-biofilm Wound Dressing Market Outlook, 2018 – 2031
3.1. Global Anti-biofilm Wound Dressing Market Outlook, by Mode of Mechanism, Value (US$ Mn), 2018 – 2031
3.1.1. Key Highlights
3.1.1.1. Physical
3.1.1.1.1. Manual Debridement
3.1.1.1.2. Pulse Electrical Field
3.1.1.1.3. Ultrasound Debridement
3.1.1.1.4. Others
3.1.1.2. Chemical
3.1.1.2.1. Ionic Silver
3.1.1.2.2. Iodine
3.1.1.2.3. EDTA
3.1.1.2.4. Others
3.1.1.3. Biological
3.1.1.3.1. Dispersin B
3.1.1.3.2. Lactoferrin
3.1.1.3.3. Bacteriophage
3.1.1.3.4. Others
3.2. Global Anti-biofilm Wound Dressing Market Outlook, by Application, Value (US$ Mn), 2018 – 2031
3.2.1. Key Highlights
3.2.1.1. Chronic Wounds
3.2.1.1.1. Diabetic Foot Ulcers
3.2.1.1.2. Pressure Ulcers
3.2.1.1.3. Venous Leg Ulcers
3.2.1.1.4. Others
3.2.1.2. Acute Wounds
3.2.1.2.1. Surgical & Traumatic Wounds
3.2.1.2.2. Burn Wounds
3.2.1.2.3. Others
3.3. Global Anti-biofilm Wound Dressing Market Outlook, by Region, Value (US$ Mn), 2018 – 2031
3.3.1. Key Highlights
3.3.1.1. North America
3.3.1.2. Europe
3.3.1.3. Asia Pacific
3.3.1.4. Latin America
3.3.1.5. Middle East & Africa
4. North America Anti-biofilm Wound Dressing Market Outlook, 2018 – 2031
4.1. North America Anti-biofilm Wound Dressing Market Outlook, by Mode of Mechanism, Value (US$ Mn), 2018 – 2031
4.1.1. Key Highlights
4.1.1.1. Physical
4.1.1.1.1. Manual Debridement
4.1.1.1.2. Pulse Electrical Field
4.1.1.1.3. Ultrasound Debridement
4.1.1.1.4. Others
4.1.1.2. Chemical
4.1.1.2.1. Ionic Silver
4.1.1.2.2. Iodine
4.1.1.2.3. EDTA
4.1.1.2.4. Others
4.1.1.3. Biological
4.1.1.3.1. Dispersin B
4.1.1.3.2. Lactoferrin
4.1.1.3.3. Bacteriophage
4.1.1.3.4. Others
4.2. North America Anti-biofilm Wound Dressing Market Outlook, by Application, Value (US$ Mn), 2018 – 2031
4.2.1. Key Highlights
4.2.1.1. Chronic Wounds
4.2.1.1.1. Diabetic Foot Ulcers
4.2.1.1.2. Pressure Ulcers
4.2.1.1.3. Venous Leg Ulcers
4.2.1.1.4. Others
4.2.1.2. Acute Wounds
4.2.1.2.1. Surgical & Traumatic Wounds
4.2.1.2.2. Burn Wounds
4.2.1.2.3. Others
4.3. North America Anti-biofilm Wound Dressing Market Outlook, by Country, Value (US$ Mn), 2018 – 2031
4.3.1. Key Highlights
4.3.1.1. U.S. Anti-biofilm Wound Dressing Market by Mode of Mechanism, Value (US$ Mn), 2018 – 2031
4.3.1.2. U.S. Anti-biofilm Wound Dressing Market by Application, Value (US$ Mn), 2018 – 2031
4.3.1.3. Canada Anti-biofilm Wound Dressing Market by Mode of Mechanism, Value (US$ Mn), 2018 – 2031
4.3.1.4. Canada Anti-biofilm Wound Dressing Market by Application, Value (US$ Mn), 2018 – 2031
4.3.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Anti-biofilm Wound Dressing Market Outlook, 2018 – 2031
5.1. Europe Anti-biofilm Wound Dressing Market Outlook, by Mode of Mechanism, Value (US$ Mn), 2018 – 2031
5.1.1. Key Highlights
5.1.1.1. Physical
5.1.1.1.1. Manual Debridement
5.1.1.1.2. Pulse Electrical Field
5.1.1.1.3. Ultrasound Debridement
5.1.1.1.4. Others
5.1.1.2. Chemical
5.1.1.2.1. Ionic Silver
5.1.1.2.2. Iodine
5.1.1.2.3. EDTA
5.1.1.2.4. Others
5.1.1.3. Biological
5.1.1.3.1. Dispersin B
5.1.1.3.2. Lactoferrin
5.1.1.3.3. Bacteriophage
5.1.1.3.4. Others
5.2. Europe Anti-biofilm Wound Dressing Market Outlook, by Application, Value (US$ Mn), 2018 – 2031
5.2.1. Key Highlights
5.2.1.1. Chronic Wounds
5.2.1.1.1. Diabetic Foot Ulcers
5.2.1.1.2. Pressure Ulcers
5.2.1.1.3. Venous Leg Ulcers
5.2.1.1.4. Others
5.2.1.2. Acute Wounds
5.2.1.2.1. Surgical & Traumatic Wounds
5.2.1.2.2. Burn Wounds
5.2.1.2.3. Others
5.2.2. BPS Analysis/Market Attractiveness Analysis
5.3. Europe Anti-biofilm Wound Dressing Market Outlook, by Country, Value (US$ Mn), 2018 – 2031
5.3.1. Key Highlights
5.3.1.1. Germany Anti-biofilm Wound Dressing Market by Mode of Mechanism, Value (US$ Mn), 2018 – 2031
5.3.1.2. Germany Anti-biofilm Wound Dressing Market by Application, Value (US$ Mn), 2018 – 2031
5.3.1.3. U.K. Anti-biofilm Wound Dressing Market by Mode of Mechanism, Value (US$ Mn), 2018 – 2031
5.3.1.4. U.K. Anti-biofilm Wound Dressing Market by Application, Value (US$ Mn), 2018 – 2031
5.3.1.5. France Anti-biofilm Wound Dressing Market by Mode of Mechanism, Value (US$ Mn), 2018 – 2031
5.3.1.6. France Anti-biofilm Wound Dressing Market by Application, Value (US$ Mn), 2018 – 2031
5.3.1.7. Italy Anti-biofilm Wound Dressing Market by Mode of Mechanism, Value (US$ Mn), 2018 – 2031
5.3.1.8. Italy Anti-biofilm Wound Dressing Market by Application, Value (US$ Mn), 2018 – 2031
5.3.1.9. Turkey Anti-biofilm Wound Dressing Market by Mode of Mechanism, Value (US$ Mn), 2018 – 2031
5.3.1.10. Turkey Anti-biofilm Wound Dressing Market by Application, Value (US$ Mn), 2018 – 2031
5.3.1.11. Russia Anti-biofilm Wound Dressing Market by Mode of Mechanism, Value (US$ Mn), 2018 – 2031
5.3.1.12. Russia Anti-biofilm Wound Dressing Market by Application, Value (US$ Mn), 2018 – 2031
5.3.1.13. Rest of Europe Anti-biofilm Wound Dressing Market by Mode of Mechanism, Value (US$ Mn), 2018 – 2031
5.3.1.14. Rest of Europe Anti-biofilm Wound Dressing Market by Application, Value (US$ Mn), 2018 – 2031
5.3.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Anti-biofilm Wound Dressing Market Outlook, 2018 – 2031
6.1. Asia Pacific Anti-biofilm Wound Dressing Market Outlook, by Mode of Mechanism, Value (US$ Mn), 2018 – 2031
6.1.1. Key Highlights
6.1.1.1. Physical
6.1.1.1.1. Manual Debridement
6.1.1.1.2. Pulse Electrical Field
6.1.1.1.3. Ultrasound Debridement
6.1.1.1.4. Others
6.1.1.2. Chemical
6.1.1.2.1. Ionic Silver
6.1.1.2.2. Iodine
6.1.1.2.3. EDTA
6.1.1.2.4. Others
6.1.1.3. Biological
6.1.1.3.1. Dispersin B
6.1.1.3.2. Lactoferrin
6.1.1.3.3. Bacteriophage
6.1.1.3.4. Others
6.2. Asia Pacific Anti-biofilm Wound Dressing Market Outlook, by Application, Value (US$ Mn), 2018 – 2031
6.2.1. Key Highlights
6.2.1.1. Chronic Wounds
6.2.1.1.1. Diabetic Foot Ulcers
6.2.1.1.2. Pressure Ulcers
6.2.1.1.3. Venous Leg Ulcers
6.2.1.1.4. Others
6.2.1.2. Acute Wounds
6.2.1.2.1. Surgical & Traumatic Wounds
6.2.1.2.2. Burn Wounds
6.2.1.2.3. Others
6.3. Asia Pacific Anti-biofilm Wound Dressing Market Outlook, by Country, Value (US$ Mn), 2018 – 2031
6.3.1. Key Highlights
6.3.1.1. China Anti-biofilm Wound Dressing Market by Mode of Mechanism, Value (US$ Mn), 2018 – 2031
6.3.1.2. China Anti-biofilm Wound Dressing Market by Application, Value (US$ Mn), 2018 – 2031
6.3.1.3. Japan Anti-biofilm Wound Dressing Market by Mode of Mechanism, Value (US$ Mn), 2018 – 2031
6.3.1.4. Japan Anti-biofilm Wound Dressing Market by Application, Value (US$ Mn), 2018 – 2031
6.3.1.5. South Korea Anti-biofilm Wound Dressing Market by Mode of Mechanism, Value (US$ Mn), 2018 – 2031
6.3.1.6. South Korea Anti-biofilm Wound Dressing Market by Application, Value (US$ Mn), 2018 – 2031
6.3.1.7. India Anti-biofilm Wound Dressing Market by Mode of Mechanism, Value (US$ Mn), 2018 – 2031
6.3.1.8. India Anti-biofilm Wound Dressing Market by Application, Value (US$ Mn), 2018 – 2031
6.3.1.9. Southeast Asia Anti-biofilm Wound Dressing Market by Mode of Mechanism, Value (US$ Mn), 2018 – 2031
6.3.1.10. Southeast Asia Anti-biofilm Wound Dressing Market by Application, Value (US$ Mn), 2018 – 2031
6.3.1.11. Rest of Asia Pacific Anti-biofilm Wound Dressing Market by Mode of Mechanism, Value (US$ Mn), 2018 – 2031
6.3.1.12. Rest of Asia Pacific Anti-biofilm Wound Dressing Market by Application, Value (US$ Mn), 2018 – 2031
6.3.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Anti-biofilm Wound Dressing Market Outlook, 2018 – 2031
7.1. Latin America Anti-biofilm Wound Dressing Market Outlook, by Mode of Mechanism, Value (US$ Mn), 2018 – 2031
7.1.1. Key Highlights
7.1.1.1. Physical
7.1.1.1.1. Manual Debridement
7.1.1.1.2. Pulse Electrical Field
7.1.1.1.3. Ultrasound Debridement
7.1.1.1.4. Others
7.1.1.2. Chemical
7.1.1.2.1. Ionic Silver
7.1.1.2.2. Iodine
7.1.1.2.3. EDTA
7.1.1.2.4. Others
7.1.1.3. Biological
7.1.1.3.1. Dispersin B
7.1.1.3.2. Lactoferrin
7.1.1.3.3. Bacteriophage
7.1.1.3.4. Others
7.2. Latin America Anti-biofilm Wound Dressing Market Outlook, by Application, Value (US$ Mn), 2018 – 2031
7.2.1. Key Highlights
7.2.1.1. Chronic Wounds
7.2.1.1.1. Diabetic Foot Ulcers
7.2.1.1.2. Pressure Ulcers
7.2.1.1.3. Venous Leg Ulcers
7.2.1.1.4. Others
7.2.1.2. Acute Wounds
7.2.1.2.1. Surgical & Traumatic Wounds
7.2.1.2.2. Burn Wounds
7.2.1.2.3. Others
7.3. Latin America Anti-biofilm Wound Dressing Market Outlook, by Country, Value (US$ Mn), 2018 – 2031
7.3.1. Key Highlights
7.3.1.1. Brazil Anti-biofilm Wound Dressing Market by Mode of Mechanism, Value (US$ Mn), 2018 – 2031
7.3.1.2. Brazil Anti-biofilm Wound Dressing Market by Application, Value (US$ Mn), 2018 – 2031
7.3.1.3. Mexico Anti-biofilm Wound Dressing Market by Mode of Mechanism, Value (US$ Mn), 2018 – 2031
7.3.1.4. Mexico Anti-biofilm Wound Dressing Market by Application, Value (US$ Mn), 2018 – 2031
7.3.1.5. Argentina Anti-biofilm Wound Dressing Market by Mode of Mechanism, Value (US$ Mn), 2018 – 2031
7.3.1.6. Argentina Anti-biofilm Wound Dressing Market by Application, Value (US$ Mn), 2018 – 2031
7.3.1.7. Rest of Latin America Anti-biofilm Wound Dressing Market by Mode of Mechanism, Value (US$ Mn), 2018 – 2031
7.3.1.8. Rest of Latin America Anti-biofilm Wound Dressing Market by Application, Value (US$ Mn), 2018 – 2031
7.3.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Anti-biofilm Wound Dressing Market Outlook, 2018 – 2031
8.1. Middle East & Africa Anti-biofilm Wound Dressing Market Outlook, by Mode of Mechanism, Value (US$ Mn), 2018 – 2031
8.1.1. Key Highlights
8.1.1.1. Physical
8.1.1.1.1. Manual Debridement
8.1.1.1.2. Pulse Electrical Field
8.1.1.1.3. Ultrasound Debridement
8.1.1.1.4. Others
8.1.1.2. Chemical
8.1.1.2.1. Ionic Silver
8.1.1.2.2. Iodine
8.1.1.2.3. EDTA
8.1.1.2.4. Others
8.1.1.3. Biological
8.1.1.3.1. Dispersin B
8.1.1.3.2. Lactoferrin
8.1.1.3.3. Bacteriophage
8.1.1.3.4. Others
8.2. Middle East & Africa Anti-biofilm Wound Dressing Market Outlook, by Application, Value (US$ Mn), 2018 – 2031
8.2.1. Key Highlights
8.2.1.1. Chronic Wounds
8.2.1.1.1. Diabetic Foot Ulcers
8.2.1.1.2. Pressure Ulcers
8.2.1.1.3. Venous Leg Ulcers
8.2.1.1.4. Others
8.2.1.2. Acute Wounds
8.2.1.2.1. Surgical & Traumatic Wounds
8.2.1.2.2. Burn Wounds
8.2.1.2.3. Others
8.3. Middle East & Africa Anti-biofilm Wound Dressing Market Outlook, by Country, Value (US$ Mn), 2018 – 2031
8.3.1. Key Highlights
8.3.1.1. GCC Anti-biofilm Wound Dressing Market by Mode of Mechanism, Value (US$ Mn), 2018 – 2031
8.3.1.2. GCC Anti-biofilm Wound Dressing Market by Application, Value (US$ Mn), 2018 – 2031
8.3.1.3. South Africa Anti-biofilm Wound Dressing Market by Mode of Mechanism, Value (US$ Mn), 2018 – 2031
8.3.1.4. South Africa Anti-biofilm Wound Dressing Market by Application, Value (US$ Mn), 2018 – 2031
8.3.1.5. Egypt Anti-biofilm Wound Dressing Market by Mode of Mechanism, Value (US$ Mn), 2018 – 2031
8.3.1.6. Egypt Anti-biofilm Wound Dressing Market by Application, Value (US$ Mn), 2018 – 2031
8.3.1.7. Nigeria Anti-biofilm Wound Dressing Market by Mode of Mechanism, Value (US$ Mn), 2018 – 2031
8.3.1.8. Nigeria Anti-biofilm Wound Dressing Market by Application, Value (US$ Mn), 2018 – 2031
8.3.1.9. Rest of Middle East & Africa Anti-biofilm Wound Dressing Market by Mode of Mechanism, Value (US$ Mn), 2018 – 2031
8.3.1.10. Rest of Middle East & Africa Anti-biofilm Wound Dressing Market by Application, Value (US$ Mn), 2018 – 2031
8.3.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. Manufacturer vs by Application Heatmap
9.2. Company Market Share Analysis, 2023
9.3. Competitive Dashboard
9.4. Company Profiles
9.4.1. ConvaTec
9.4.1.1. Company Overview
9.4.1.2. Product Portfolio
9.4.1.3. Financial Overview
9.4.1.4. Business Strategies and Development
9.4.2. Smith & Nephew PLC
9.4.2.1. Company Overview
9.4.2.2. Product Portfolio
9.4.2.3. Financial Overview
9.4.2.4. Business Strategies and Development
9.4.3. Urgo Medical
9.4.3.1. Company Overview
9.4.3.2. Product Portfolio
9.4.3.3. Financial Overview
9.4.3.4. Business Strategies and Development
9.4.4. Coloplast
9.4.4.1. Company Overview
9.4.4.2. Product Portfolio
9.4.4.3. Financial Overview
9.4.4.4. Business Strategies and Development
9.4.5. 3M
9.4.5.1. Company Overview
9.4.5.2. Product Portfolio
9.4.5.3. Financial Overview
9.4.5.4. Business Strategies and Development
9.4.6. Urgo Medical
9.4.6.1. Company Overview
9.4.6.2. Product Portfolio
9.4.6.3. Financial Overview
9.4.6.4. Business Strategies and Development
9.4.7. Next Science
9.4.7.1. Company Overview
9.4.7.2. Product Portfolio
9.4.7.3. Financial Overview
9.4.7.4. Business Strategies and Development
9.4.8. Monarch Labs
9.4.8.1. Company Overview
9.4.8.2. Product Portfolio
9.4.8.3. Financial Overview
9.4.8.4. Business Strategies and Development
9.4.9. Mega Pharma (Pvt) Ltd.
9.4.9.1. Company Overview
9.4.9.2. Product Portfolio
9.4.9.3. Financial Overview
9.4.9.4. Business Strategies and Development
9.4.10. BioMonde
9.4.10.1. Company Overview
9.4.10.2. Product Portfolio
9.4.10.3. Financial Overview
9.4.10.4. Business Strategies and Development
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations